Dr Philip Wong

Philip Wong has published over 25 papers. He is a Clinical Senior Lecturer in Medicine, Department of Medicine and Health Sciences at the University of Auckland and his areas of research interest are in the liver and viral hepatitis related trials.

View Philip's Profile

Articles and Publications

Gane E, Portmann B, Saxena R, Wong P, Ramage J and Williams R. Nodular
regenerative hyperplasia of the liver graft after liver transplantation. Hepatology, 1994; 20 (1 Pt 1): p. 88-94.

Wong PYN, Devlin J, Gane E, Ramage J, Portmann B and Roger Williams. FK506
rescue therapy for intractable liver allograft rejection. Transplant International 1994, 7: 70-76.

Howard L, Fahy T, Wong P, Sherman D, Gane E and Williams R. Psychiatric
outcome in alcoholic liver transplant patients. QJM, 1994; 87 (12): p. 731-6.

Devlin J, Wong P, Williams R, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Bismuth H, Groth C. FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group Transpl Int. 1994;7 Suppl 1:S64-9.

Mondragon RS, Karani JB, Heaton ND, Thomas S, Wong PY, O'Grady JG, Tan KC
and Williams R. The use of percutaneous transluminal angioplasty in hepatic artery stenosis after transplantation. Transplantation, 1994; 57 (2): p. 228-31.

Wong PY, McPeake JR, Portmann B, Tan KC, Naoumov NV and Williams R. Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. American Journal of Gastroenterology, 1995; 90 (1): p. 29-34.

Marinos G, Naoumov NV, Rossol S, Torre F, Wong PY, Gallati H, Portmann B and Williams R. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology, 1995; 108 (5): p. 1453-63.

Wong PY, Marinos G, Peakman M, Tredger JM, Lau JY, Vergani D, Naoumov NV
and Williams R. FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. Liver Transplantation & Surgery, 1995; 1 (6): p. 362-70.

Torre F, Wong PY, Macartney M, Williams R, Naoumov NV. Evolution of wild-type and precore mutant HBV infection after liver transplantation. J Med Virol. 1999 Sep;59(1):5-13.

Marinos G, Rossol S, Carucci P, Wong PY, Donaldson P, Hussain MJ, Vergani D, Portmann BC, Williams R, Naoumov NV. Immunopathogenesis of hepatitis B virus recurrence after liver transplantation. Transplantation. 2000, 69(4):559-68.

Lal D, Lane M, Wong P. Complications of endoscopic retrograde cholangiopancreatography. NZ Med J. 2003, 116(1177):496.

Ogra R, Lane M, Wong P, Fraser A. Endoscopic injection therapy for non-variceal upper gastrointestinal bleeding at Auckland Hospital. NZ Med J. 2002 2;115(1166):255

Wallace DF, Browett P, Wong P, Kua H, Ameratunga R, Subramaniam VN. Identification of ferroportin disease in the Indian subcontinent. Gut 2005. 54;4:567-8 2

Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred S, Schroeder B, Croxson MC, Garkavenko O. Hepatitis E in New Zealand. J Gastroenterol Hepatol 2007, 22;8:1236-40.

Leung UC, Wong PY, Roberts RH, Koea JB. Gall bladder polyps in sclerosing
cholangitis: does the 1-cm rule apply? ANNZ J Surg 2007, 77(5):355-7.

Book: J M Tredger and P Y N Wong. Laboratory monitoring of drug levels and drug interactions. In: "The Practice of Liver transplantation" Editors Roger Williams, Bernard Portmann and K-C Tan. Churchill Livingston, London & Edinburgh, 1995. Pages 211-224

Book: J Ramage, P Wong, K Hayllar, R Williams. Overall survival results: quality of life and management. In "The Practice of Liver Transplantation". Editors Roger Williams, Bernard Portmann and K-C Tan. Churchill Livingston, London & Edinburgh, 1995. Pages 257-270.